Fundraising Fox

Carlos Loya

Investor

Venture Partner & Founder at 82VS

Cambridge, Massachusetts, United States

About

Carlos Loya is a scientist and biotech executive who served as a founding team member at SAGE Therapeutics and Praxis Precision Medicines, where he contributed to the strategy, discovery, and development of multiple programs including Zulresso™ and Zurzuvae™, both of which received FDA approval. His expertise spans neuroscience and RNA biology, with professional experience in corporate development, licensing, partnerships, drug discovery strategy, and capital raising.

Experience

  1. 82VSVenture Partner2024 — 2026Greater Boston
  2. 82VSExecutive In Residence2021 — 2024Cambridge, Massachusetts, United States
  3. Aldebaran TherapeuticsFounder & Board Member2022 — 2026Greater Boston
  4. Alloy Therapeutics, Inc.Head of Partnering | Genetic Medicines2024 — 2025Greater Boston
  5. Praxis Precision Medicines, Inc.Global Commercial Lead2020 — 2021Cambridge, Massachusetts, United States
  6. Praxis Precision Medicines, Inc.Director of Corporate Development2018 — 2021Cambridge, Massachusetts, United States
  7. Collegium Pharmaceutical, Inc.Associate Director of Corporate Development2016 — 2018Greater Boston
  8. inVentiv Health - Campbell AllianceEngagement Manager, Corporate Development & Strategy Practice2014 — 2016Greater Boston
  9. Sage TherapeuticsDrug Discovery and Porfolio Strategy2011 — 2014Cambridge, MA
  10. Third Rock VenturesConsultant2011Boston, MA
  11. Harvard Medical SchoolKirschstein & Ryan Graduate Research Fellow2005 — 2011Greater Boston
  12. Siemens Venture CapitalBusiness Analyst Intern2010Greater Boston

Education

  1. Harvard Medical SchoolPhD, Neurobiology
  2. New Mexico State UniversityBS, Biochemistry
  3. University of Lausanne - UNILBS, Biochemistry and French

Skills & more

Lifesciences31Biotechnology39Genetics20Neuroscience23Biochemistry15Entrepreneurship12Genomics9Drug Discovery20Genetic EngineeringMarket Analysis4Venture Capital2RNAi
+12 moreBiopharmaceuticalsLife SciencesCell CultureCommercializationPharmacologyMolecular BiologyPharmaceutical IndustryClinical DevelopmentStrategyNegotiationBusiness DevelopmentFinance

Languages English · French · Spanish

From Carlos's professional profile.

Same school

Shared employers

Colleagues at 82VS